Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03847376 |
|---|---|
| Brief Title: | Pre-Approval Access to Rilpivirine Long Acting (RPV LA) Injectable Suspension for the Treatment of a Participant With Human Immunodeficiency Virus (HIV)-1 Infection |
| First Submitted : | February 18, 2019 |
| First Submitted that Met QC Criteria : | February 18, 2019 |
| First Posted : | February 20, 2019 |
| Last Update Submitted that Met QC Criteria : | March 31, 2021 |
| Last Update Posted : | April 5, 2021 |